Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China.
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961. doi: 10.1371/journal.pntd.0008961. eCollection 2020 Dec.
This study attempts to understand coronavirus disease 2019 (COVID-19) vaccine demand and hesitancy by assessing the public's vaccination intention and willingness-to-pay (WTP). Confidence in COVID-19 vaccines produced in China and preference for domestically-made or foreign-made vaccines was also investigated.
A nationwide cross-sectional, self-administered online survey was conducted on 1-19 May 2020. The health belief model (HBM) was used as a theoretical framework for understanding COVID-19 vaccination intent and WTP.
A total of 3,541 complete responses were received. The majority reported a probably yes intent (54.6%), followed by a definite yes intent (28.7%). The perception that vaccination decreases the chances of getting COVID-19 under the perceived benefit construct (OR = 3.14, 95% CI 2.05-4.83) and not being concerned about the efficacy of new COVID-19 vaccines under the perceived barriers construct (OR = 1.65, 95% CI 1.31-2.09) were found to have the highest significant odds of a definite intention to take the COVID-19 vaccine. The median (interquartile range [IQR]) of WTP for COVID-19 vaccine was CNY¥200/US$28 (IQR CNY¥100-500/USD$14-72). The highest marginal WTP for the vaccine was influenced by socio-economic factors. The majority were confident (48.7%) and completely confident (46.1%) in domestically-made COVID-19 vaccine. 64.2% reported a preference for a domestically-made over foreign-made COVID-19 vaccine.
The findings demonstrate the utility of HBM constructs in understanding COVID-19 vaccination intent and WTP. It is important to improve health promotion and reduce the barriers to COVID-19 vaccination.
本研究通过评估公众的接种意愿和支付意愿(WTP),试图了解 2019 年冠状病毒病(COVID-19)疫苗的需求和犹豫。还调查了公众对中国生产的 COVID-19 疫苗的信心和对国产或进口疫苗的偏好。
2020 年 5 月 1 日至 19 日进行了全国性的横断面、自我管理的在线调查。健康信念模型(HBM)被用作理解 COVID-19 疫苗接种意愿和 WTP 的理论框架。
共收到 3541 份完整回复。大多数人报告了可能的意愿(54.6%),其次是明确的意愿(28.7%)。在感知益处构念中,接种疫苗降低感染 COVID-19 的可能性(OR=3.14,95%CI 2.05-4.83),而在感知障碍构念中,对新 COVID-19 疫苗的疗效不担心(OR=1.65,95%CI 1.31-2.09),这两个构念被认为对明确接种 COVID-19 疫苗的意愿具有最高的显著优势比。COVID-19 疫苗的支付意愿中位数(四分位距[IQR])为人民币 200 元/美元 28 元(IQR 人民币 100-500 元/美元 14-72 元)。对疫苗的最高边际支付意愿受到社会经济因素的影响。大多数人对国产 COVID-19 疫苗有信心(48.7%)和完全信心(46.1%)。64.2%的人表示更倾向于国产而非进口 COVID-19 疫苗。
研究结果表明 HBM 结构在理解 COVID-19 疫苗接种意愿和 WTP 方面具有实用性。重要的是要改善健康促进和减少 COVID-19 疫苗接种的障碍。